SLP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
SLP is not a good buy right now for an impatient investor. The stock is in a confirmed downtrend (bearish moving averages and worsening MACD), sentiment is pressured by repeated law-firm investigation headlines, and insider selling has surged. While RSI is extremely oversold and could spark a short bounce, the current setup favors avoiding/stepping aside rather than buying immediately.
Price/Trend: SLP is trending bearishly with SMA_200 > SMA_20 > SMA_5, confirming a sustained downtrend. Momentum: MACD histogram is -0.349 and negatively expanding, signaling downside momentum is strengthening. RSI: RSI_6 at 15.468 is deeply oversold, increasing odds of a reflex bounce, but oversold conditions can persist in strong downtrends. Levels: Pivot 19.129 (well above current), resistance at 20.732/21.722; support at S1 17.527 (currently below this level) and S2 16.537 (nearby). With price ~16.885, the stock is hovering just above the next support (S2), meaning downside risk remains if 16.537 breaks.
Intellectia Proprietary Trading Signals
RSI is extremely oversold, which can trigger a sharp short-term mean-reversion bounce. Pattern-based projection suggests a modest positive bias over 1 week to 1 month (+2.09% next week, +6.67% next month). TD Cowen recently raised its price target to $19 (from $16), implying some perceived upside if fundamentals stabilize.
create ongoing headline/legal overhang and can depress sentiment. Insider selling is flagged as rising sharply (selling amount up 2417.79% over the last month), a significant negative signal. Trend is technically bearish (bearish MAs, MACD worsening) and price is below S1 support (17.527), risking a move toward/through S2 (16.537). Options volume is heavily put-skewed (put-call volume ratio 10.0), indicating near-term caution/bearish positioning.
Latest quarter: 2026/Q1. Revenue fell to $18.421M (-2.66% YoY), showing top-line softness. However, profitability improved sharply: Net income rose to $0.676M (+228.16% YoY) and EPS to $0.03 (+200% YoY), alongside a much stronger gross margin (66.79, +23.71% YoY). Overall: margin/profitability improved, but revenue is still contracting, which limits confidence in an immediate growth re-acceleration.
Recent analyst trend: sentiment weakened into late 2025 with BTIG downgrading to Neutral from Buy (12/18) citing declining recent revenues, muted FY26 growth outlook, a $77M write-down, and limited recovery visibility. More recently (01/08), TD Cowen raised its price target to $19 from $16 but maintained a Hold, framing upside as dependent on clearer guidance and sector recovery positioning. Wall Street pros/cons: Pros—potential upside if guidance improves and profitability gains hold; Cons—soft demand visibility, prior write-down concerns, and near-term headwinds keep ratings cautious (Hold/Neutral bias).
